The Genetic Basis of Early T-cell Precursor Acute Lymphoblastic Leukaemia

Early T-cell precursor acute lymphoblastic leukaemia (ETP ALL) is an aggressive malignancy of unknown genetic basis. We performed whole-genome sequencing of 12 ETP ALL cases and assessed the frequency of the identified somatic mutations in 94 T-cell acute lymphoblastic leukaemia cases. ETP ALL was characterized by activating mutations in genes regulating cytokine receptor and RAS signalling (67% of cases; NRAS, KRAS, FLT3, IL7R, JAK3, JAK1, SH2B3 and BRAF), inactivating lesions disrupting haematopoietic development (58%; GATA3, ETV6, RUNX1, IKZF1 and EP300) and histone-modifying genes (48%; EZH2, EED, SUZ12, SETD2 and EP300). We also identified new targets of recurrent mutation including DNM2, ECT2L and RELN. The mutational spectrum is similar to myeloid tumours, and moreover, the global transcriptional profile of ETP ALL was similar to that of normal and myeloid leukaemia haematopoietic stem cells. These findings suggest that addition of myeloid-directed therapies might improve the poor outcome of ETP ALL.

Citing Articles

Acute Leukemia of Ambiguous Lineage: Diagnosis and Evaluation by Flow Cytometry.

Fuda F, Chen W Cancers (Basel). 2025; 17(5).

PMID: 40075717 PMC: 11898493. DOI: 10.3390/cancers17050871.

Polycomb repressive complex 2 (PRC2) pathway's role in cancer cell plasticity and drug resistance.

Goleij P, Heidari M, Tabari M, Hadipour M, Rezaee A, Javan A Funct Integr Genomics. 2025; 25(1):53.

PMID: 40048009 DOI: 10.1007/s10142-025-01563-8.

Development of multivalent CAR T cells as dual immunotherapy and conditioning agents.

Bubb Q, Balood M, Seir G, Swartzrock L, Haslett E, Ho K Mol Ther Oncol. 2025; 33(1):200944.

PMID: 40034967 PMC: 11872492. DOI: 10.1016/j.omton.2025.200944.

Integrated Whole Genome and Transcriptome Sequencing as a Framework for Pediatric and Adolescent AML Diagnosis and Risk Assessment.

Wang L, Voss R, Pastor V, Cardenas M, Kumar P, Maciaszek J Res Sq. 2025; .

PMID: 39975890 PMC: 11838756. DOI: 10.21203/rs.3.rs-5775959/v1.

Native stem cell transcriptional circuits define cardinal features of high-risk leukemia.

Wang Q, Boccalatte F, Xu J, Gambi G, Nadorp B, Akter F J Exp Med. 2025; 222(4).

PMID: 39969525 PMC: 11837855. DOI: 10.1084/jem.20231349.

References

Yamashita Y, Yuan J, Suetake I, Suzuki H, Ishikawa Y, Choi Y . Array-based genomic resequencing of human leukemia. Oncogene. 2010; 29(25):3723-31. DOI: 10.1038/onc.2010.117. View

Weng A, Ferrando A, Lee W, Morris 4th J, Silverman L, Sanchez-Irizarry C . Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science. 2004; 306(5694):269-71. DOI: 10.1126/science.1102160. View

Wang J, Mullighan C, Easton J, Roberts S, Heatley S, Ma J . CREST maps somatic structural variation in cancer genomes with base-pair resolution. Nat Methods. 2011; 8(8):652-4. PMC: 3527068. DOI: 10.1038/nmeth.1628. View

Notta F, Doulatov S, Laurenti E, Poeppl A, Jurisica I, Dick J . Isolation of single human hematopoietic stem cells capable of long-term multilineage engraftment. Science. 2011; 333(6039):218-21. DOI: 10.1126/science.1201219. View

Wada H, Masuda K, Satoh R, Kakugawa K, Ikawa T, Katsura Y . Adult T-cell progenitors retain myeloid potential. Nature. 2008; 452(7188):768-72. DOI: 10.1038/nature06839. View

Pui C, Robison L, Look A . Acute lymphoblastic leukaemia. Lancet. 2008; 371(9617):1030-43. DOI: 10.1016/S0140-6736(08)60457-2. View

Zahirieh A, Nesbit M, Ali A, Wang K, He N, Stangou M . Functional analysis of a novel GATA3 mutation in a family with the hypoparathyroidism, deafness, and renal dysplasia syndrome. J Clin Endocrinol Metab. 2005; 90(4):2445-50. DOI: 10.1210/jc.2004-1969. View

Mullighan C, Su X, Zhang J, Radtke I, Phillips L, Miller C . Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia. N Engl J Med. 2009; 360(5):470-80. PMC: 2674612. DOI: 10.1056/NEJMoa0808253. View

Hosoya T, Maillard I, Engel J . From the cradle to the grave: activities of GATA-3 throughout T-cell development and differentiation. Immunol Rev. 2010; 238(1):110-25. PMC: 2965564. DOI: 10.1111/j.1600-065X.2010.00954.x. View

10.

Kleppe M, Mentens N, Tousseyn T, Wlodarska I, Cools J . MOHITO, a novel mouse cytokine-dependent T-cell line, enables studies of oncogenic signaling in the T-cell context. Haematologica. 2011; 96(5):779-83. PMC: 3084928. DOI: 10.3324/haematol.2010.035931. View

11.

Gelsi-Boyer V, Trouplin V, Adelaide J, Aceto N, Remy V, Pinson S . Genome profiling of chronic myelomonocytic leukemia: frequent alterations of RAS and RUNX1 genes. BMC Cancer. 2008; 8:299. PMC: 2588460. DOI: 10.1186/1471-2407-8-299. View

12.

Gaidzik V, Bullinger L, Schlenk R, Zimmermann A, Rock J, Paschka P . RUNX1 mutations in acute myeloid leukemia: results from a comprehensive genetic and clinical analysis from the AML study group. J Clin Oncol. 2011; 29(10):1364-72. DOI: 10.1200/JCO.2010.30.7926. View

13.

Gilliland D . Molecular genetics of human leukemias: new insights into therapy. Semin Hematol. 2002; 39(4 Suppl 3):6-11. DOI: 10.1053/shem.2002.36921. View

14.

Dicker F, Haferlach C, Sundermann J, Wendland N, Weiss T, Kern W . Mutation analysis for RUNX1, MLL-PTD, FLT3-ITD, NPM1 and NRAS in 269 patients with MDS or secondary AML. Leukemia. 2010; 24(8):1528-32. DOI: 10.1038/leu.2010.124. View

15.

Yokota S, Nakao M, Horiike S, Seriu T, Iwai T, Kaneko H . Mutational analysis of the N-ras gene in acute lymphoblastic leukemia: a study of 125 Japanese pediatric cases. Int J Hematol. 1998; 67(4):379-87. DOI: 10.1016/s0925-5710(98)00015-2. View

16.

Rothenberg E, Moore J, Yui M . Launching the T-cell-lineage developmental programme. Nat Rev Immunol. 2007; 8(1):9-21. PMC: 3131407. DOI: 10.1038/nri2232. View

17.

Margueron R, Reinberg D . The Polycomb complex PRC2 and its mark in life. Nature. 2011; 469(7330):343-9. PMC: 3760771. DOI: 10.1038/nature09784. View

18.

Hong S, Shugart Y, Huang D, Shahwan S, Grant P, Hourihane J . Autosomal recessive lissencephaly with cerebellar hypoplasia is associated with human RELN mutations. Nat Genet. 2000; 26(1):93-6. DOI: 10.1038/79246. View

19.

Ziegler S, Liu Y . Thymic stromal lymphopoietin in normal and pathogenic T cell development and function. Nat Immunol. 2006; 7(7):709-14. DOI: 10.1038/ni1360. View

20.

Eppert K, Takenaka K, Lechman E, Waldron L, Nilsson B, van Galen P . Stem cell gene expression programs influence clinical outcome in human leukemia. Nat Med. 2011; 17(9):1086-93. DOI: 10.1038/nm.2415. View